Related Experiment Videos
[Liver-specific MR contrast agents: current status and prospects].
1Department of Diagnostic Radiology, Keio University School of Medicine.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica
|October 26, 2001
Summary
Liver-specific MRI contrast agents, including superparamagnetic iron oxide (SPIO) particles and hepatobiliary agents, enhance liver imaging. These agents improve the detection and characterization of liver neoplasms.
Area of Science:
- Radiology and Medical Imaging
- Biomedical Engineering
- Pharmacology
Context:
- Liver imaging relies on various techniques, with contrast agents playing a crucial role in enhancing diagnostic accuracy.
- Existing methods for liver lesion detection can be multistep and time-consuming.
Purpose:
- To review and compare liver-specific magnetic resonance (MR) contrast agents, including superparamagnetic iron oxide (SPIO) particles and hepatobiliary paramagnetic agents.
- To highlight the potential of these agents in improving the diagnosis and characterization of hepatic neoplasms.
Summary:
- Superparamagnetic iron oxide (SPIO) particles are taken up by reticuloendothelial cells, causing negative liver parenchyma enhancement on T2/T2*-weighted images.
- Hepatobiliary paramagnetic agents are taken up by hepatocytes, providing positive, sustained liver enhancement on T1-weighted images, improving tumor-liver contrast.
- Ferumoxides are clinically available, with other agents in development, offering a potential 'one-stop' diagnostic approach.
Impact:
- Liver-specific MR contrast agents offer a promising alternative to current multistep diagnostic protocols.
- These agents have the potential to improve the detection and characterization of liver neoplasms, potentially altering patient treatment decisions.
- Further cost-benefit analyses are needed to confirm the clinical utility and reliability of these advanced imaging agents.